Inclusive healthcare in light of the new MASLD guidelines: Should people living with HIV be screened for liver fibrosis?

Competing Interests: Conflict of interest Giada Sebastiani has acted as speaker for Merck, Gilead, Abbvie, Novo Nordisk, served as an advisory board member for Merck, Novo Nordisk, Gilead, and has received unrestricted research funding from Theratecnologies Inc. Juergen Rockstroh consults for Gallapagos, Abivax, Gilead, Merck, ViiV and Janssen. Giovanni Guaraldi advised and received grants from Gilead, ViiV, and Merck. He received grants from Janssen. Felice Cinque and Antonio Cascio have nothing to declare. Please refer to the accompanying ICMJE disclosure forms for further details.